The gut-brain axis link to Alzheimer's is confirmed, but the real story is who profits from this microbial revolution in dementia research.
The hype around BBB-crossing antibody technology masks a brutal reality. Is this truly a breakthrough, or just another pharmaceutical mirage in the fight against neurodegeneration?
Forget plaques. A hidden brain problem is emerging as the true **Alzheimer's early warning**. The implications for diagnostics are staggering.
New Alzheimer's breakthroughs in mice spark hope, but this 'memory restoration' hides a critical flaw: the translational gap.